A detailed history of Vanguard Group Inc transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 53,972 shares of CLBT stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,972
Previous 47,630 13.32%
Holding current value
$1.06 Million
Previous $569,000 59.58%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$11.61 - $17.52 $73,630 - $111,111
6,342 Added 13.32%
53,972 $908,000
Q2 2024

Aug 13, 2024

BUY
$10.38 - $12.5 $182,002 - $219,175
17,534 Added 58.26%
47,630 $569,000
Q3 2023

Nov 14, 2023

BUY
$6.86 - $8.18 $68,147 - $81,260
9,934 Added 49.27%
30,096 $230,000
Q4 2021

Feb 14, 2022

BUY
$7.8 - $11.24 $157,263 - $226,620
20,162 New
20,162 $162,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $3.74B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.